HK1019003A1 - Use of 2-amino-6-a-propylamino-4,5,6,7- tetrahydrobenzothiazole(pram ipexol) as an anti-depressant drug - Google Patents

Use of 2-amino-6-a-propylamino-4,5,6,7- tetrahydrobenzothiazole(pram ipexol) as an anti-depressant drug

Info

Publication number
HK1019003A1
HK1019003A1 HK98113329A HK98113329A HK1019003A1 HK 1019003 A1 HK1019003 A1 HK 1019003A1 HK 98113329 A HK98113329 A HK 98113329A HK 98113329 A HK98113329 A HK 98113329A HK 1019003 A1 HK1019003 A1 HK 1019003A1
Authority
HK
Hong Kong
Prior art keywords
ipexol
tetrahydrobenzothiazole
pram
propylamino
amino
Prior art date
Application number
HK98113329A
Other languages
English (en)
Inventor
Franco Borsini
Rudolf Hammer
Joachim Mierau
Erich Lehr
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of HK1019003A1 publication Critical patent/HK1019003A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
HK98113329A 1992-12-05 1998-12-14 Use of 2-amino-6-a-propylamino-4,5,6,7- tetrahydrobenzothiazole(pram ipexol) as an anti-depressant drug HK1019003A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4241013A DE4241013A1 (de) 1992-12-05 1992-12-05 Verwendung von 2-Amino-6-n-propyl-amino-4,5,6,7-tetrahydrobenzothiazol als Arzneimittel mit antidepressiver Wirkung
PCT/EP1993/003389 WO1994013287A1 (de) 1992-12-05 1993-12-02 Verwendung von 2-amino-6-a-propyl-amino-4,5,6,7-tetrahydrobenzothiazol (pramipexol) als arzneimittel mit antidepressiver wirkung

Publications (1)

Publication Number Publication Date
HK1019003A1 true HK1019003A1 (en) 2000-01-14

Family

ID=6474503

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98113329A HK1019003A1 (en) 1992-12-05 1998-12-14 Use of 2-amino-6-a-propylamino-4,5,6,7- tetrahydrobenzothiazole(pram ipexol) as an anti-depressant drug

Country Status (29)

Country Link
US (1) US6191153B1 (xx)
EP (1) EP0675717B1 (xx)
JP (1) JP3221880B2 (xx)
KR (1) KR100311165B1 (xx)
CN (1) CN1052400C (xx)
AT (1) ATE183091T1 (xx)
AU (1) AU674378B2 (xx)
BG (1) BG62475B1 (xx)
CA (1) CA2150131C (xx)
CZ (1) CZ282679B6 (xx)
DE (2) DE4241013A1 (xx)
DK (1) DK0675717T3 (xx)
ES (1) ES2136725T3 (xx)
FI (1) FI952734A (xx)
GR (1) GR3031521T3 (xx)
HK (1) HK1019003A1 (xx)
HU (1) HU221014B1 (xx)
IL (1) IL107870A (xx)
MX (1) MX9307644A (xx)
NO (1) NO306930B1 (xx)
NZ (1) NZ258876A (xx)
PL (1) PL309282A1 (xx)
RU (1) RU2157685C2 (xx)
SG (1) SG49228A1 (xx)
SK (1) SK281441B6 (xx)
TW (1) TW362973B (xx)
UA (1) UA35604C2 (xx)
WO (1) WO1994013287A1 (xx)
ZA (1) ZA939065B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650420A (en) * 1994-12-15 1997-07-22 Pharmacia & Upjohn Company Pramipexole as a neuroprotective agent
US6156777A (en) 1994-12-15 2000-12-05 Pharmacia & Upjohn Company Use of pramipexole as a neuroprotective agent
US6001861A (en) * 1998-01-16 1999-12-14 Pharmacia & Upjohn Company Use of pramipexole in the treatment of restless legs syndrome
DE19830201A1 (de) * 1998-07-07 2000-01-13 Boehringer Ingelheim Pharma Mittel mit antidepressiver Wirkung
WO2000006162A1 (de) * 1998-07-27 2000-02-10 Boehringer Ingelheim Pharma Kg Mittel mit antidepressiver wirkung, mit pramipexol und einem weiteren antidepressivum
PE20011074A1 (es) 2000-02-23 2001-10-04 Upjohn Co Uso de pramipexol en el tratamiento de trastornos de adiccion
WO2002004409A2 (en) * 2000-07-06 2002-01-17 Us Gov Health & Human Serv Tetrahydrobenzothiazole analogues as neuroprotective agents
US20020165246A1 (en) * 2001-03-05 2002-11-07 Andrew Holman Administration of sleep restorative agents
EP1260221A3 (en) * 2001-05-23 2002-12-18 Pfizer Products Inc. Combination treatment for depression and anxiety
DE10138275A1 (de) * 2001-08-10 2003-02-27 Boehringer Ingelheim Pharma Verbindungen zur Beseitigung der Anhedonie
AR040682A1 (es) * 2002-07-25 2005-04-13 Pharmacia Corp Forma de dosificacion una vez al dia de pramipexol
DE102004006808A1 (de) * 2004-02-11 2005-09-01 Grünenthal GmbH Substituierte 4,5,6,7-Tetrahydro-benzothiazol-2-ylamin-Verbindungen
CN101005831B (zh) * 2004-08-13 2010-11-10 贝林格尔·英格海姆国际有限公司 包含普拉克索或其可药用盐的延长释放片剂
CA2576386A1 (en) * 2004-08-13 2006-02-16 Boehringer Ingelheim International Gmbh Extended release pellet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof
RU2413510C2 (ru) * 2005-04-04 2011-03-10 Такеда Фармасьютикал Компани Лимитед Профилактический или терапевтический агент против депрессии или тревожного расстройства
JP2009511618A (ja) * 2005-10-18 2009-03-19 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 中度から重度のむずむず脚症候群(rls)を治療するためのプラミペキソールの使用
EP1988875A2 (en) * 2006-02-10 2008-11-12 Boehringer Ingelheim International GmbH Modified release formulation
WO2007090883A1 (en) * 2006-02-10 2007-08-16 Boehringer Ingelheim International Gmbh Extended release formulation
AU2018251604B2 (en) * 2017-04-10 2022-04-14 Chase Therapeutics Corporation NK1-antagonist combination and method for treating synucleinopathies
US11266633B2 (en) 2017-06-30 2022-03-08 Chase Therapeutics Corporation NK-1 antagonist compositions and methods for use in treating depression
CN108802584B (zh) * 2018-06-29 2020-12-08 广东工业大学 一种变压器绝缘纸老化状态评估方法
TWI672472B (zh) * 2018-08-15 2019-09-21 鄭映芳 飲料製冰機裝置
CN110028464B (zh) * 2019-04-26 2022-11-18 浙江海洋大学 一种南极真菌次级代谢衍生物BTZ-one及其制备方法和应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
DE3843227A1 (de) * 1988-12-22 1990-07-05 Boehringer Ingelheim Kg Neue verwendung von 2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzthiazol
DE3930282A1 (de) * 1989-09-11 1991-03-21 Boehringer Ingelheim Kg Verwendung von dopamin-autorezeptor-agonisten bei der behandlung von drogenabhaengigkeit

Also Published As

Publication number Publication date
KR950703953A (ko) 1995-11-17
KR100311165B1 (ko) 2001-12-28
PL309282A1 (en) 1995-10-02
IL107870A0 (en) 1994-04-12
HU221014B1 (hu) 2002-07-29
UA35604C2 (uk) 2001-04-16
JP3221880B2 (ja) 2001-10-22
BG62475B1 (bg) 1999-12-30
TW362973B (en) 1999-07-01
FI952734A0 (fi) 1995-06-05
GR3031521T3 (en) 2000-01-31
CA2150131C (en) 2004-09-21
CN1091635A (zh) 1994-09-07
MX9307644A (es) 1994-06-30
DE4241013A1 (de) 1994-06-09
RU2157685C2 (ru) 2000-10-20
SK281441B6 (sk) 2001-03-12
SG49228A1 (en) 1998-05-18
DE59309733D1 (de) 1999-09-16
JPH08504201A (ja) 1996-05-07
CN1052400C (zh) 2000-05-17
IL107870A (en) 1996-12-05
ZA939065B (en) 1994-08-04
AU5715294A (en) 1994-07-04
NO952207D0 (no) 1995-06-02
US6191153B1 (en) 2001-02-20
NO306930B1 (no) 2000-01-17
ATE183091T1 (de) 1999-08-15
SK74095A3 (en) 1996-05-08
EP0675717A1 (de) 1995-10-11
HUT71798A (en) 1996-02-28
HU9501623D0 (en) 1995-08-28
DK0675717T3 (da) 2000-02-28
WO1994013287A1 (de) 1994-06-23
NZ258876A (en) 1997-07-27
FI952734A (fi) 1995-06-05
AU674378B2 (en) 1996-12-19
BG99700A (bg) 1996-04-30
CZ144095A3 (en) 1996-03-13
CA2150131A1 (en) 1994-06-23
ES2136725T3 (es) 1999-12-01
NO952207L (no) 1995-06-02
CZ282679B6 (cs) 1997-08-13
EP0675717B1 (de) 1999-08-11

Similar Documents

Publication Publication Date Title
HK1019003A1 (en) Use of 2-amino-6-a-propylamino-4,5,6,7- tetrahydrobenzothiazole(pram ipexol) as an anti-depressant drug
UA34428C2 (uk) Заміщені фенілімідазолідини, спосіб їх одержання, фармацевтична композиція, проміжні сполуки
IL128425A0 (en) Taxane derivatives their preparation and pharmaceutical compositions containing them
MY123193A (en) Novel 2-(iminomethyl)amino-phenyl derivatives,preparation,application as medicines and compositions containing same
MY124146A (en) Novel 2-(iminomethyl) amino-phenyl derivatives, preparation, application as medicines and pharmaceutical compositions containing same
MY121908A (en) 3-amidopyrazole derivatives, process for preparing these and pharmaceutical compositions containing them.
PH23778A (en) Labdan compounds,pharmaceutical compositions and use
UA39101C2 (uk) ПОХІДНІ 11<font face="Symbol">b</font>-БЕНЗАЛЬДОКСИМ-ЕСТРА-4,9-ДІЄНУ, СПОСІБ ЇХ ОДЕРЖАННЯ І ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ З АНТИПРОГЕСТИНОВОЮ АКТИВНІСТЮ
PL338348A1 (en) Thiazolobenzenoheterocyclic compounds, their production and drugs containing them
ZA986336B (en) Medicaments comprising polyhydroxybutylpyrazines novel polyhydroxybutylpyrazines and their preparation
CS318690A3 (en) Pharmaceutical composition usable for depression therapy
IL85560A (en) Pharmaceutical compositions containing an antidepressant of the structural type of 10,11-dihydrodibenzo(b,f)azepine,a dibenzo-(a,d)(1,4)cycloheptadiene and/or a 10,11-dihydro-benzo-(b,f)oxepine and a pyrolidinone derivative
ES2184285T3 (es) Compuestos farmaceuticos que contienen diclorhidrato de cinconina.
AU4146000A (en) Remedies for glomerulosclerosis
DK0587048T3 (da) Heteroarenylpiperaziner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
JO1711B1 (en) Therapeutic agents
ES2179668T3 (es) Un compuesto wf002, su produccion y su uso.
IT8719351A0 (it) Composti ad attivita'epatoprotettrice e mucolitica, procedimento per la loro preparazione e composizioni farmaceutiche relative.
MX9606264A (es) Compuestos de 1-fenil-2-dimetilaminometil-ciclohexan-1-ol como sustancias farmacologicas activas.
IT8619384A0 (it) Composti ad attivita'epatoprotettrice e mucolitica, procedimento per la loro preparazione e composizioni farmaceutiche relative.

Legal Events

Date Code Title Description
PF Patent in force
PE Patent expired

Effective date: 20131201